Data protection Impressum

Biotech

Backed by its parent company Nanobacterie's fourth-place in nanomedicine patent rankings by Marks and Clerk, AlphaOnco Swiss channels the synergy of Franco-Swiss collaboration to bring forth groundbreaking cancer treatments.

Nanomedicine pioneer Nanobacterie achieves remarkable patent ranking

23 August 2023

In the heart of Neuchâtel, CSEM is a powerhouse of technological innovation.

Top innovations out of Neuchâtel’s CSEM

21 August 2023

The canton of Bern, with its continual focus on advancing medicine through research, technology, and collaboration, stands as destination rich in opportunities for companies aiming to grow and innovate in the fields of medicine and life sciences.

Bern’s thriving ecosystem for life sciences innovation

9 August 2023

EPITERNA focuses on developing therapies that can extend the healthy lifespan of companion dogs, cats, and humans.

Longevity start-up EPITERNA raises EUR 10 million to slow ageing and extend lifespan

7 August 2023

This agreement will ease trade of medicines with the United States and reduce the administrative burden for the industry.

Switzerland and USA implement mutual recognition agreement to streamline pharmaceutical trade

31 July 2023

bNovate raises CHF 12 million to enhance global water safety

20 June 2023

Merck unveils its cutting-edge Biotech Development Center in Corsier-sur-Vevey

12 June 2023

Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp

7 June 2023

Geneva start-ups Fluosphera, Kylys Aesthetics and Consulto receive FIF support

16 May 2023

NewBiologix pioneers breakthrough gene therapies with USD 50 million investment

16 May 2023

1 … 12 13 14 15 16 17 18 19 20 … 24